<DOC>
	<DOCNO>NCT01015872</DOCNO>
	<brief_summary>The purpose study evaluate relationship prostanoids various outcome sleep disturbance , hypertension arteriosclerosis patient sleep apnea syndrome ( SAS ) . In patient introduce continuous positive airway pressure ( CPAP ) treatment , effect CPAP also evaluate .</brief_summary>
	<brief_title>The Roles Prostanoids Patients With Sleep Apnea Syndrome</brief_title>
	<detailed_description>SAS characterize abnormality sleep hypoxemia apnea hypopnea , follow systemic inflammation organ dysfunction like cardiovascular disease . Systemic inflammation cause activation arachidonic acid metabolism , produce prostaglandin ( PGs ) leukotrienes ( LTs ) . In addition , significant relationship PGD2 PGE2 sleep , PGF2Î± hypertension , PGI2 thromboxane platelet aggregation report . Therefore , hypothesize many prostanoids affect pathophysiology SAS . However , relationship prostanoids clinical outcome patient SAS unknown . Although CPAP major treatment SAS , effect CPAP prostanoids know , either . Thus , purpose study evaluate relationship .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Subjects hospitalize Kyoto University Hospital careful examination SAS Subjects severe respiratory disease , severe heart disease , severe vascular disease , severe diabetes mellitus . Subjects take nonsteroidal antiinflammatory drug , steroid immunosuppressant .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>sleep apnea syndrome</keyword>
	<keyword>CPAP</keyword>
	<keyword>prostanoids</keyword>
</DOC>